DYN Dyne Therapeutics Inc

Price (delayed)

$17.49

Market cap

$895.59M

P/E Ratio

N/A

Dividend/share

N/A

EPS

N/A

Enterprise value

$585.24M

Sector: Healthcare
Industry: Biotechnology

Highlights

The equity has grown by 40% from the previous quarter
Dyne Therapeutics's quick ratio has increased by 14% from the previous quarter

Key stats

What are the main financial stats of DYN
Market
Shares outstanding
51.21M
Market cap
$895.59M
Enterprise value
$585.24M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.88
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
N/A
EBIT
N/A
EBITDA
N/A
Free cash flow
N/A
Per share
EPS
N/A
Free cash flow per share
N/A
Book value per share
$9.29
Revenue per share
N/A
TBVPS
$9.94
Balance sheet
Total assets
$491.71M
Total liabilities
$13.45M
Debt
$596,000
Equity
$478.26M
Working capital
$473.62M
Liquidity
Debt to equity
0
Current ratio
36.21
Quick ratio
35.92
Net debt/EBITDA
N/A
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
N/A
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DYN stock price

How has the Dyne Therapeutics stock price performed over time
Intraday
3%
1 week
-6.52%
1 month
1.92%
1 year
N/A
YTD
-16.71%
QTD
12.62%

Financial performance

How have Dyne Therapeutics's revenue and profit performed over time
Revenue
N/A
Gross profit
N/A
Operating income
N/A
Net income
N/A
Gross margin
N/A
Net margin
N/A

Growth

What is Dyne Therapeutics's growth rate over time

Valuation

What is Dyne Therapeutics stock price valuation
P/E
N/A
P/B
1.88
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The equity has grown by 40% from the previous quarter

Efficiency

How efficient is Dyne Therapeutics business performance

Dividends

What is DYN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DYN.

Financial health

How did Dyne Therapeutics financials performed over time
The company's total assets rose by 39% QoQ
The total liabilities has increased by 23% since the previous quarter
The debt is 100% smaller than the equity
The equity has grown by 40% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.